ArticleOncoimmunology
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD
Nikolai Siebert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
trialcites it